IM Cannabis Corp. Stock price

Equities

IMCC

CA44969Q3070

Pharmaceuticals

Market Closed - Canadian Securities Exchange 03:27:02 2024-03-18 pm EDT 5-day change 1st Jan Change
0.48 CAD 0.00% Intraday chart for IM Cannabis Corp. +5.49% +4.35%
Sales 2023 * 49.22M 36.3M Sales 2024 * 56.35M 41.55M Capitalization 6.43M 4.74M
Net income 2023 * -8M -5.9M Net income 2024 * -3M -2.21M EV / Sales 2023 * 0.13 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 0.11 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 63.91%
More Fundamentals * Assessed data
Dynamic Chart
1 week+5.49%
Current month+9.09%
1 month+17.07%
3 months+10.34%
6 months-36.84%
Current year+4.35%
More quotes
1 week
0.43
Extreme 0.43
0.51
1 month
0.38
Extreme 0.38
0.51
Current year
0.24
Extreme 0.24
0.54
1 year
0.24
Extreme 0.24
1.90
3 years
0.24
Extreme 0.24
101.90
5 years
0.24
Extreme 0.24
144.00
10 years
0.24
Extreme 0.24
144.00
More quotes
Date Price Change Volume
24-03-18 0.48 -4.00% 26,299
24-03-15 0.5 +16.28% 45,285
24-03-14 0.43 -5.49% 800

Delayed Quote Canadian Securities Exchange, March 18, 2024 at 03:27 pm EDT

More quotes
IM Cannabis Corp. is a Canada-based medical cannabis company. The Company operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), which held a cultivation license to breed, grow and supply medical cannabis products in Israel. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centres and logistical hubs in Israel. The Company operates through Adjupharm GmbH in Europe, which is a medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses granted by German regulatory authorities that allow for import/export capability with requisite permits. The Company operates through Trichome and its subsidiaries Trichome JWC Acquisition Corp. and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.48 CAD
Average target price
3.45 CAD
Spread / Average Target
+618.75%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock IM Cannabis Corp. - Canadian Securities Exchange